Get started
Author

Polyxeni Alexiou

Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
2009 · Polyxeni Alexiou, Kyriaki Pegklidou, et al. · Current Medicinal Chemistry · 233
Synthesis of Hydroxyapatite, β-Tricalcium Phosphate and Biphasic Calcium Phosphate Particles to Act as Local Delivery Carriers of Curcumin: Loading, Release and In Vitro Studies
2018 · Despoina Xidaki, Panagiota Agrafioti, et al. · Materials · 90
PDF
A Diverse Series of Substituted Benzenesulfonamides as Aldose Reductase Inhibitors with Antioxidant Activity: Design, Synthesis, and in Vitro Activity
2010 · Polyxeni Alexiou, Vassilis J. Demopoulos · Journal of Medicinal Chemistry · 62
Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin
2020 · Marina Sagnou, Fedor N. Novikov, et al. · European Journal of Medicinal Chemistry · 52
Novel aldose reductase inhibitors: a patent survey (2006 – present)
2012 · Maria Chatzopoulou, Polyxeni Alexiou, et al. · Expert Opinion on Therapeutic Patents · 48
The aldose reductase inhibitory capacity of Sorbus domestica fruit extracts depends on their phenolic content and may be useful for the control of diabetic complications
2008 · A Termentzi, P. Alexiou, et al. · Die Pharmazie · 36
PDF
Rationally Designed Less Toxic SPD‐304 Analogs and Preliminary Evaluation of Their TNF Inhibitory Effects
2014 · Polyxeni Alexiou, Athanasios Papakyriakou, et al. · Archiv der Pharmazie · 30
Design and synthesis of N-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors
2008 · Polyxeni Alexiou, Ioannis Nicolaou, et al. · Bioorganic & Medicinal Chemistry · 22
Synthesis and biological evaluation of potential small moleculeinhibitors of tumor necrosis factor
2015 · Christos Papaneophytou, Polyxeni Alexiou, et al. · MedChemComm · 17
Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
2005 · Vassilis Demopoulos, Nazlaa Zaher, et al. · Drug Design Reviews - Online · 17
Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic Index
2020 · Vagelis Rinotas, Athanasios Papakyriakou, et al. · Journal of Medicinal Chemistry · 16
Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit morphine's rewarding effect in rats
2014 · Vicky Katsidoni, Polyxeni Alexiou, et al. · Psychopharmacology · 15
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study
2025 · Amalia Papanikolopoulou, Vasiliki Rapti, et al. · Pathogens · 11
PDF
Patent Foramen Ovale Closure in Special Clinical Situations: More Questions Than Answers?
2024 · Anastasios Apostolos, Polyxeni Alexiou, et al. · Life · 10
PDF
Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitors: Interpreting the Discrepancy Between Clinical Trials and Real-World Data
2025 · Amalia Papanikolopoulou, Helena Michalopoulou, et al. · Cureus · 9
PDF
Modulating Sympathetic Nervous System With the Use of SGLT2 Inhibitors: Where There Is Smoke, There Is Fire?
2024 · Kyriakos Dimitriadis, Daphne Pitsiori, et al. · Journal of Cardiovascular Pharmacology · 8
Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and Mortality
2025 · Dimitrios Terentes-Printzios, Maria Eleni Koilakou, et al. · JACC Advances · 7
Isatin thiosemicarbazone-blended polymer films for biomedical applications: surface morphology, characterisation and preliminary biological assessment
2016 · David Mallinson, Polyxeni Alexiou, et al. · RSC Advances · 7
PDF
Aqueous Solubility Enhancement for Bioassays of Insoluble Inhibitors and QSPR Analysis: A TNF-α Study
2017 · Anthi Mettou, Christos Papaneophytou, et al. · SLAS DISCOVERY · 5
The Burden of COVID-19 in Adult Patients With Hematological Malignancies: A Single-center Experience After the Implementation of Mass-vaccination Programs Against SARS-CoV-2
2023 · VASILIKI RAPTI, AMALIA PAPANIKOLOPOULOU, et al. · In Vivo · 2
PDF
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers of COVID-19 irrespective of patients immunosuppression status: a case-control retrospective single-center study
2024 · Amalia Papanikolopoulou, Eftychia Eirini Maria Gourdoupari, et al. · Journal of Global Antimicrobial Resistance · 1
Novel Chemotypes in Pharmacochemical Approaches
2007 · Vassilis J. Demopoulos, Ioannis Nicolaou, et al. · Springer eBooks · 1
Five-Year Outcomes With the Allegra Versus the Evolut Self-Expanding Valve in Transcatheter Aortic Valve Replacement
2026 · Polyxeni Alexiou, Mathias Wolfrum, et al. · Structural Heart
PDF
Short‐ and Long‐Term Outcomes After Transcatheter Aortic Valve Implantation With Large Self‐Expanding Valves
2026 · Polyxeni Alexiou, Federico Moccetti, et al. · Catheterization and Cardiovascular Interventions
PDF
Discrepancies in cardiovascular toxicity of immune checkpoint inhibitors: evidence from trials and real-world data
2026 · H D M Helena Michalopoulou, A P Amalia Papanikolopoulou, et al. · European Heart Journal Supplements
Works count: 34
Citation count: 699
H-index: 12
I10-index: 14
Year
Topic
Type